Filing Details
- Accession Number:
- 0001562180-23-004477
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-25 16:05:57
- Reporting Period:
- 2023-05-23
- Accepted Time:
- 2023-05-25 16:05:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1678660 | Prelude Therapeutics Inc | PRLD | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1329010 | Laurent Chardonnet | C/O Prelude Therapeutics Incorporated 200 Powder Mill Road Wilmington DE 19801 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-05-23 | 5,000 | $5.50 | 42,165 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The reported total includes 1,292 shares of common stock the reporting person has acquired since the date of his last ownership report through the issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c).
Billionaire Hedge Funds
